Uni-Bio Science Group Limited (HKG:0690)

Uni-Bio Science Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	657	358	452	458	533	735
Market Cap Growth	96.43%	-20.75%	-1.35%	-14.08%	-27.43%	-26.98%
Enterprise Value	576	272	363	366	435	663
Last Close Price	0.11	0.06	0.07	0.07	0.08	0.11
PE Ratio	7.28	4.33	6.38	11.90	-	-
PS Ratio	1.11	0.65	0.93	1.04	1.51	3.52
PB Ratio	1.72	1.10	1.76	2.35	3.06	3.88
P/TBV Ratio	1.73	1.11	1.78	2.39	3.13	3.97
P/FCF Ratio	19.95	12.48	11.56	22.65	147.83	-
P/OCF Ratio	9.26	5.37	4.57	9.42	44.29	-
EV/Sales Ratio	0.98	0.49	0.75	0.83	1.23	3.17
EV/EBITDA Ratio	4.47	2.38	3.93	6.14	39.96	-
EV/EBIT Ratio	5.26	2.67	4.49	7.74	-	-
EV/FCF Ratio	17.48	9.46	9.29	18.08	120.49	-
Debt / Equity Ratio	0.30	0.37	0.24	0.12	0.03	0.02
Debt / EBITDA Ratio	0.89	1.01	0.63	0.35	0.36	-
Debt / FCF Ratio	3.46	4.20	1.58	1.13	1.55	-
Net Debt / Equity Ratio	-0.21	-0.19	-0.31	-0.44	-0.49	-0.39
Net Debt / EBITDA Ratio	-0.66	-0.56	-0.86	-1.44	-7.79	4.04
Net Debt / FCF Ratio	-2.47	-2.21	-2.04	-4.24	-23.48	3.89
Asset Turnover	1.13	1.19	1.38	1.57	1.36	0.76
Inventory Turnover	3.62	2.62	2.62	2.87	2.72	1.85
Quick Ratio	2.93	2.06	1.70	1.85	1.76	2.73
Current Ratio	3.40	2.58	2.07	2.22	2.19	3.01
Return on Equity (ROE)	26.27%	28.41%	31.37%	20.87%	-10.77%	-33.11%
Return on Assets (ROA)	13.12%	13.73%	14.39%	10.54%	-1.16%	-8.41%
Return on Invested Capital (ROIC)	33.75%	42.10%	52.77%	42.34%	-4.70%	-28.01%
Return on Capital Employed (ROCE)	24.00%	25.90%	27.40%	23.40%	-2.80%	-19.20%
Earnings Yield	13.91%	23.10%	15.68%	8.40%	-3.67%	-9.70%
FCF Yield	5.01%	8.01%	8.65%	4.41%	0.68%	-2.57%
Dividend Yield	2.52%	4.78%	-	-	-	-
Buyback Yield / Dilution	3.52%	3.53%	-0.07%	0.17%	0.57%	-2.04%
Total Shareholder Return	6.08%	8.31%	-0.07%	0.17%	0.57%	-2.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.